A detailed history of Advisor Net Financial, Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Advisor Net Financial, Inc holds 22,379 shares of AZN stock, worth $1.46 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
22,379
Previous 22,237 0.64%
Holding current value
$1.46 Million
Previous $1.73 Million 0.52%
% of portfolio
0.14%
Previous 0.16%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$76.67 - $87.62 $10,887 - $12,442
142 Added 0.64%
22,379 $1.74 Million
Q2 2024

Jul 16, 2024

BUY
$66.81 - $80.83 $17,637 - $21,339
264 Added 1.2%
22,237 $1.73 Million
Q1 2024

Apr 12, 2024

BUY
$61.03 - $69.57 $129,383 - $147,488
2,120 Added 10.68%
21,973 $1.49 Million
Q4 2023

Jan 19, 2024

BUY
$61.89 - $69.28 $176,572 - $197,655
2,853 Added 16.78%
19,853 $1.34 Million
Q3 2023

Oct 12, 2023

BUY
$64.85 - $71.7 $176,002 - $194,593
2,714 Added 19.0%
17,000 $1.15 Million
Q2 2023

Jul 14, 2023

BUY
$69.91 - $75.81 $753,559 - $817,155
10,779 Added 307.36%
14,286 $1.02 Million
Q1 2023

Apr 28, 2023

BUY
$63.15 - $71.6 $123,395 - $139,906
1,954 Added 125.82%
3,507 $243,000
Q4 2022

Jan 13, 2023

BUY
$54.21 - $70.44 $31,983 - $41,559
590 Added 61.27%
1,553 $0
Q3 2022

Oct 04, 2022

SELL
$53.02 - $135.75 $16,754 - $42,897
-316 Reduced 24.71%
963 $53,000
Q2 2022

Jul 07, 2022

SELL
$59.26 - $71.14 $8,237 - $9,888
-139 Reduced 9.8%
1,279 $85,000
Q1 2022

Apr 14, 2022

BUY
$55.72 - $67.12 $18,833 - $22,686
338 Added 31.3%
1,418 $94,000
Q4 2021

Jan 19, 2022

BUY
$54.02 - $63.83 $5,023 - $5,936
93 Added 9.42%
1,080 $63,000
Q3 2021

Oct 15, 2021

BUY
$55.56 - $60.79 $8,945 - $9,787
161 Added 19.49%
987 $59,000
Q1 2021

Apr 14, 2021

SELL
$47.16 - $54.44 $4,716 - $5,444
-100 Reduced 10.8%
826 $41,000
Q4 2020

Feb 04, 2021

SELL
$48.52 - $58.02 $582 - $696
-12 Reduced 1.28%
926 $46,000
Q3 2020

Nov 06, 2020

BUY
$53.07 - $61.1 $689 - $794
13 Added 1.41%
938 $51,000
Q2 2020

Aug 26, 2020

BUY
$43.1 - $55.31 $10,861 - $13,938
252 Added 37.44%
925 $49,000
Q1 2020

May 14, 2020

SELL
$37.79 - $51.33 $3,249 - $4,414
-86 Reduced 11.33%
673 $30,000
Q4 2019

Feb 12, 2020

SELL
$42.46 - $50.46 $16,304 - $19,376
-384 Reduced 33.6%
759 $38,000
Q3 2019

Oct 23, 2019

BUY
$40.12 - $45.47 $280 - $318
7 Added 0.62%
1,143 $51,000
Q2 2019

Jul 15, 2019

SELL
$37.28 - $41.68 $15,844 - $17,714
-425 Reduced 27.23%
1,136 $47,000
Q1 2019

May 14, 2019

SELL
$35.49 - $43.02 $23,991 - $29,081
-676 Reduced 30.22%
1,561 $63,000
Q3 2018

Nov 14, 2018

BUY
$34.76 - $39.72 $7,508 - $8,579
216 Added 10.69%
2,237 $89,000
Q2 2018

Jul 27, 2018

SELL
$34.55 - $37.05 $380 - $407
-11 Reduced 0.54%
2,021 $71,000
Q4 2017

Feb 27, 2018

BUY
$32.09 - $34.78 $65,206 - $70,672
2,032
2,032 $71,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.